Table 2.
Adherence rates of patients newly prescribed insulin therapy
Adherence assessment | Pharmaceutical care group (n=114)
|
Control group (n=113)
|
||||
---|---|---|---|---|---|---|
Baseline | After interventions | P | Baseline | After interventions | P | |
Morisky–Green test | ||||||
Adherent, n (%) | 58 (50.8%) | 92 (80.7%) | <0.01 | 59 (52.2%) | 66 (58.4%) | 0.596 |
Nonadherent, n (%) | 56 (49.1%) | 22 (19.3%) | <0.01 | 54 (47.7%) | 47 (41.6%) | 0.528 |
Dispensed drug history | ||||||
Adherent, n (%) | 63 (55.2%) | 95 (83.3%) | <0.01 | 64 (56.6%) | 67 (59.3%) | 0.584 |
Nonadherent, n (%) | 51 (44.7%) | 19 (16.7%) | <0.01 | 49 (43.3%) | 46 (40.7%) | 0.558 |